Tuesday, 21 January 2020

Japan News

  • Thermo Fisher enters into agreement Fujirebio

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2012

    Singapore: Thermo Fisher Scientific signed a long-term license agreement with Fujirebio to make its biomarker assay Procalcitonin (PCT) available on the Lumipulse family of laboratory ins...Read more

  • Bayer colorectal cancer drug gets Japanese nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2013

    Singapore: Japan's Ministry of Health, Labor and Welfare (MHLW) has approved Bayer HealthCare and Onyx Pharmaceuticals's Stivarga (regorafenib) tablets for the treatment of patients with me...Read more

  • Astellas, Ambit terminate cancer drug deal

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2013

    Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint development and commercialization of FMS-like tyrosine kinase-3 (FLT3)...Read more

  • Edison Pharma, DSP enter $4 bn metablosim drug deal

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2014

    Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan's Dainippon Sumitomo Pharma (DSP) for the development of drugs target...Read more

  • Gilead files NDA for Hep C drug in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jun, 2014

    Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices Agency (PMDA) for approval of sofosbuvir, a once-daily nucleotid...Read more

  • AnGes, Mitsubishi Tanabe sign MoU to market Collategene

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: AnGes MG entered into a definitive agreement with Mitsubishi Tanabe Pharma for the exclusive marketing rights of Collategene (DNA plasmid with HGF gene) as a treatment for peri...Read more

  • What the future holds for the APAC CRO market?

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Japan scientists pioneer new stem cell technology

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2012

    Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), succeeded in fabricating two types of cell matrix materials that mimic...Read more

  • Astellas gets FDA nod for kidney transplant drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kid...Read more

  • Global collaborations is the way forward for drug discovery

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma through a multitude of outsourcing deals. A large...Read more

  • Pfizer, Mylan enter generics deal in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 Aug, 2012

    Singapore: Pfizer and Mylan have signed a definitive agreement to establish an exclusive long-term strategic collaboration in order to develop, manufacture, distribute and market generic dr...Read more

  • Takara Bio enters deal with Invivoscribe

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Singapore: Japanese firm Takara Bio has entered into an agreement with Invivoscribe Technologies to grant the latter licenses to facilitate and conduct patent-covered tests for the presence...Read more

  • NuVasive spine surgery implant approved in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Singapore: NuVasive, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, has received Japan's approval of the CoRoent Large ...Read more

  • Mitsubishi to acquire Medicago at $1.16 per share

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

    Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and virus-like particles (VL...Read more

  • Kinetic launches portable negative pressure therapy

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Apr, 2013

    Singapore: US-based Kinetic Concepts (KCI) has launched ActiVAC Therapy System for in-patient use in Japan, which is a lightweight, portable negative pressure therapy system that makes usin...Read more

  • Terumo and Biosensors to sell Nabori DES system

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Terumo and Biosensors International announced an extension of their existing licensing agreements, under which Terumo can continue to incorporate BioMatrix technology in the...Read more

  • Otsuka, Lundbeck files NDA for schizophrenia drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for brexpiprazo...Read more

  • HealthPatch MD receives Japanese nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2015

    Singapore: Vital Connect recently announced that its wearable device HealthPatch MD has received approval for sale in the Japanese markets. The device has received, Medical Device Ninsho ce...Read more



Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls